Chrysos (ASX:C79) — Material Events
ASX:C79 · 12 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Chrysos Surges with 49% Revenue Growth and $200m Debt Facility BoostHigh
Chrysos reports 49% revenue growth and 152% EBITDA surge in 1H FY26, expands PhotonAssay deployments and secures $200m debt facility
18 Feb 2026
·Financial Results
·90
Chrysos Accelerates Growth with Newmont Deal and Strong FY25 ResultsHigh
Chrysos posts strong FY25 growth, secures Newmont MSA, and guides higher FY26 revenue and EBITDA
12 Aug 2025
·Trading Update
·90
Chrysos Surpasses One Million Samples Monthly as Global Contracts ExpandMedium
Chrysos hits record sample processing, expands contracts, and confirms FY26 guidance
4 May 2026
·Trading Update
·85
Chrysos Hits Record PhotonAssay Volumes, Eyes New Elements and AutomationMedium
Chrysos reports record PhotonAssay volumes, reiterates FY26 guidance, and advances assay technology
24 Nov 2025
·AGM Presentation
·85
Chrysos Accelerates Growth with New Contracts and 46% Revenue Surge in FY25Medium
Chrysos posts strong FY25 growth, secures major contracts, and guides higher FY26 revenue and EBITDA
12 Aug 2025
·Trading Update
·85
Chrysos Accelerates Global Growth with Newmont Deal and 46% Revenue SurgeHigh
Chrysos posts strong FY25 growth with key Newmont contract and FY26 revenue guidance of $80-90m
26 Aug 2025
·FY Results
·85
Chrysos Secures $200 Million Debt Facility to Boost PhotonAssay ExpansionMedium
Chrysos secures AUD 200 million corporate debt facility to accelerate PhotonAssay™ growth
4 June 2026
·Corporate Debt Refinancing
·85
Chrysos Accelerates Global Growth with Record PhotonAssay DeploymentsMedium
Chrysos reports strong FY25 growth, expands global footprint, reiterates FY26 guidance
24 Nov 2025
·Annual General Meeting Address
·85
Chrysos Surges with 46% Revenue Growth on PhotonAssay ExpansionMedium
Chrysos posts record FY25 results on strong PhotonAssay™ demand, expands globally
24 Nov 2025
·Annual General Meeting Chair’s Address
·80
Chrysos Confirms $66.1m FY25 Revenue, Eyes Growth with PhotonAssayMedium
Chrysos confirms FY25 revenue of $66.1m and EBITDA of $16.1m, hosts investor webinar
26 Aug 2025
·Financial Results
·75
Chrysos Grows Revenue 46% Yet Posts $8.2M Loss in FY25Medium
Chrysos reports 46% revenue growth but A$8.2M net loss for FY25; no dividends declared
26 Aug 2025
·Preliminary Final Report
·70
CSIRO Halves Stake in Chrysos but Stays Firmly OnboardMedium
CSIRO reduces Chrysos stake by half but remains committed substantial holder
26 Nov 2025
·Shareholder Update
·70
No articles in this tier for the last 12 months.
Market Mentions
5
- appeared in market wrap coverage
These are market wrap articles where Chrysos (ASX:C79) was mentioned. They reflect broader market coverage, not company-specific announcements.
Market Wrap - Week 19 (4 May -> 8 May) 2026
9 May 2026
Materials Wrap - Week 19 (4 May -> 8 May) 2026
9 May 2026
Technology Wrap - Week 19 (4 May -> 8 May) 2026
9 May 2026
Market Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
Materials Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026